John Abdelsayed, MD
Surgery · Sugar Land, TXNPI 1578983839
Payments from drug & device makers
Across 74 payments — averaging $220.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Sales And Service, LLC$10K
- AbbVie$4K
- Cytyc Surgical Products, LLC$453
- Intuitive Surgical$374
- Baxter Healthcare$313
- Stryker$161
- plus $532 from 13 others
What the payments were for
- Consulting fees$10,03061%
- Travel & lodging$5143%
- Food & beverage$5,80135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Sales And Service, LLC | 9 | $10,351 |
| AbbVie(2 entities) | 38 | $4,161 |
| Cytyc Surgical Products, LLC | 2 | $453 |
| Intuitive Surgical | 4 | $374 |
| Baxter Healthcare | 3 | $313 |
| Stryker | 1 | $161 |
| Boehringer Ingelheim | 1 | $112 |
| Medtronic | 3 | $109 |
| Davol Inc. | 1 | $45 |
| Baudax Bio Inc. | 2 | $42 |
| Kerecis Limited | 1 | $36 |
| TELA Bio, Inc. | 2 | $34 |
| Molnlycke Health Care US, LLC | 1 | $31 |
| Aroa Biosurgery Incorporated | 1 | $24 |
| Activ Surgical, Inc. | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,345 in reported general payments places this provider in the 80th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 41 | $534 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $232 |
| Neomycin Sulfate | 25 | $125 |
| Tramadol Hcl | 35 | $120 |
| Metronidazole | 30 | $95 |
Paid to pharmacies, not to this prescriber.
Other surgery in Sugar Land
- Ashish SahariaSugar Land$466K
- Funda MericHouston$20.6M
- Michael HarkinsTomball$2.7M
- Lloyd StegemannCorpus Christi$1.9M
- Douglas StoddardAustin$1.4M
- Erik WilsonBellaire$1.2M
- Thomas SerenaShenandoah$1.2M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$924K
- Isidoro WienerHouston$850K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.